| cellular amino acid metabolic process | GO:0006520 | 103 | 0.460 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.437 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.385 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.349 | |
| oxidation reduction process | GO:0055114 | 342 | 0.257 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.245 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.243 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.239 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.222 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.205 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.197 | |
| single fertilization | GO:0007338 | 82 | 0.193 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.189 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.185 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.184 | |
| protein catabolic process | GO:0030163 | 221 | 0.183 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.181 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.179 | |
| fertilization | GO:0009566 | 127 | 0.173 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.168 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.162 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.156 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.152 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.150 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.139 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.138 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.137 | |
| regulation of cell migration | GO:0030334 | 219 | 0.137 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.136 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.136 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.132 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.131 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.130 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.130 | |
| regulation of neuron death | GO:1901214 | 134 | 0.126 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.125 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.125 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.124 | |
| cell cell recognition | GO:0009988 | 44 | 0.122 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.122 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.121 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.119 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.119 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.118 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.118 | |
| regulation of secretion | GO:0051046 | 274 | 0.115 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.114 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.114 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.113 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.110 | |
| regulation of defense response | GO:0031347 | 233 | 0.110 | |
| tube formation | GO:0035148 | 140 | 0.108 | |
| viral process | GO:0016032 | 41 | 0.105 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.104 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.104 | |
| inflammatory response | GO:0006954 | 244 | 0.103 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.103 | |
| regulation of cell activation | GO:0050865 | 289 | 0.101 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.100 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.098 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.098 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.097 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.097 | |
| leukocyte migration | GO:0050900 | 124 | 0.096 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.095 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.094 | |
| cation transport | GO:0006812 | 399 | 0.091 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.090 | |
| eosinophil migration | GO:0072677 | 3 | 0.090 | |
| response to oxidative stress | GO:0006979 | 123 | 0.087 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.086 | |
| maintenance of location | GO:0051235 | 89 | 0.085 | |
| defense response to other organism | GO:0098542 | 197 | 0.082 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.082 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.081 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.080 | |
| neuron death | GO:0070997 | 154 | 0.080 | |
| muscle fiber development | GO:0048747 | 76 | 0.080 | |
| amine metabolic process | GO:0009308 | 45 | 0.080 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.079 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.079 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.078 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.078 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.078 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.078 | |
| gtp catabolic process | GO:0006184 | 143 | 0.076 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.076 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.076 | |
| muscle tissue development | GO:0060537 | 308 | 0.075 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.073 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.072 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.071 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.070 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.070 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.070 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.069 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.069 | |
| regulation of cell motility | GO:2000145 | 236 | 0.069 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.069 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.068 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.068 | |
| negative regulation of growth | GO:0045926 | 99 | 0.067 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.066 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.066 | |
| germ cell development | GO:0007281 | 185 | 0.065 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.065 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.065 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.064 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.063 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.063 | |
| spermatogenesis | GO:0007283 | 284 | 0.063 | |
| lipid catabolic process | GO:0016042 | 69 | 0.063 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.062 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.062 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.061 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.060 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.060 | |
| somatostatin signaling pathway | GO:0038170 | 2 | 0.059 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.058 | |
| striated muscle cell development | GO:0055002 | 125 | 0.058 | |
| skeletal system development | GO:0001501 | 356 | 0.057 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.056 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.055 | |
| dendrite development | GO:0016358 | 115 | 0.055 | |
| prevention of polyspermy | GO:0060468 | 4 | 0.055 | |
| mapk cascade | GO:0000165 | 281 | 0.055 | |
| cell chemotaxis | GO:0060326 | 81 | 0.055 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.054 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.054 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.053 | |
| response to peptide | GO:1901652 | 136 | 0.053 | |
| response to peptide hormone | GO:0043434 | 127 | 0.053 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.052 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.052 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.051 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.051 | |
| regulation of interleukin 1 alpha production | GO:0032650 | 4 | 0.051 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.051 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.051 | |
| stem cell differentiation | GO:0048863 | 268 | 0.050 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.050 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.050 | |
| regulation of anagen | GO:0051884 | 1 | 0.050 | |
| gland development | GO:0048732 | 330 | 0.050 | |
| adaptive immune response | GO:0002250 | 155 | 0.050 | |
| cytokine production | GO:0001816 | 319 | 0.049 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.049 | |
| chemotaxis | GO:0006935 | 247 | 0.049 | |
| myotube differentiation | GO:0014902 | 105 | 0.049 | |
| transmembrane transport | GO:0055085 | 412 | 0.049 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.049 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.049 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.048 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.048 | |
| cell recognition | GO:0008037 | 83 | 0.048 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.047 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.047 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.047 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.046 | |
| spemann organizer formation | GO:0060061 | 2 | 0.046 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.046 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.046 | |
| regulation of protein localization | GO:0032880 | 231 | 0.046 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.045 | |
| t cell proliferation | GO:0042098 | 120 | 0.045 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.045 | |
| gtp metabolic process | GO:0046039 | 144 | 0.044 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.044 | |
| cervix development | GO:0060067 | 2 | 0.044 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.044 | |
| protein tetramerization | GO:0051262 | 23 | 0.044 | |
| fat cell differentiation | GO:0045444 | 160 | 0.044 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.043 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.043 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.043 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.043 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.042 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.042 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.042 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.042 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.041 | |
| epithelium migration | GO:0090132 | 63 | 0.041 | |
| sperm egg recognition | GO:0035036 | 37 | 0.041 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.041 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.041 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.041 | |
| response to radiation | GO:0009314 | 165 | 0.041 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.041 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.040 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.040 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.040 | |
| developmental maturation | GO:0021700 | 193 | 0.040 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.039 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.039 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.039 | |
| specification of organ identity | GO:0010092 | 30 | 0.039 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.039 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.038 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.038 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.038 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.038 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.038 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.038 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.037 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.037 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.037 | |
| cellular homeostasis | GO:0019725 | 240 | 0.037 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.037 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.037 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.037 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.036 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.036 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.036 | |
| intracellular protein transport | GO:0006886 | 204 | 0.036 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.036 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.036 | |
| regulation of t helper 2 cell cytokine production | GO:2000551 | 3 | 0.035 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.035 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.035 | |
| regulation of ion transport | GO:0043269 | 215 | 0.035 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.035 | |
| dna metabolic process | GO:0006259 | 303 | 0.035 | |
| epithelial cell development | GO:0002064 | 159 | 0.035 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.035 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.035 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.035 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.034 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.034 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.034 | |
| angiogenesis | GO:0001525 | 201 | 0.034 | |
| glial cell development | GO:0021782 | 54 | 0.034 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.034 | |
| binding of sperm to zona pellucida | GO:0007339 | 34 | 0.034 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.034 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.034 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.034 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.033 | |
| male gamete generation | GO:0048232 | 285 | 0.033 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.033 | |
| immune effector process | GO:0002252 | 321 | 0.033 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.033 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.033 | |
| renal outer medulla development | GO:0072054 | 2 | 0.033 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.033 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.032 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.032 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.032 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.032 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.032 | |
| protein secretion | GO:0009306 | 111 | 0.032 | |
| protein processing | GO:0016485 | 163 | 0.031 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.031 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.031 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.031 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.031 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.031 | |
| tissue remodeling | GO:0048771 | 102 | 0.031 | |
| lung induction | GO:0060492 | 3 | 0.031 | |
| cation homeostasis | GO:0055080 | 212 | 0.031 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.031 | |
| myoblast differentiation | GO:0045445 | 52 | 0.031 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.031 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.031 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.030 | |
| epithelial tube formation | GO:0072175 | 130 | 0.030 | |
| locomotory behavior | GO:0007626 | 195 | 0.030 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.030 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.030 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.030 | |
| activation of mapk activity involved in innate immune response | GO:0035419 | 2 | 0.030 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.030 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.030 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.030 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.030 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.030 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.030 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.030 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.030 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.029 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.029 | |
| cerebellum formation | GO:0021588 | 1 | 0.029 | |
| insulin secretion | GO:0030073 | 89 | 0.029 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.029 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.029 | |
| cd4 positive alpha beta t cell cytokine production | GO:0035743 | 4 | 0.029 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.029 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.029 | |
| response to inorganic substance | GO:0010035 | 96 | 0.029 | |
| jnk cascade | GO:0007254 | 72 | 0.029 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.028 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.028 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.028 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.028 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.028 | |
| interleukin 8 production | GO:0032637 | 4 | 0.028 | |
| b cell activation | GO:0042113 | 161 | 0.027 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.027 | |
| epithelial cell migration | GO:0010631 | 63 | 0.027 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.027 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.027 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.027 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.027 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.027 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.027 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.027 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.027 | |
| nuclear import | GO:0051170 | 95 | 0.027 | |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 29 | 0.027 | |
| innate immune response | GO:0045087 | 157 | 0.027 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.027 | |
| glucose homeostasis | GO:0042593 | 128 | 0.026 | |
| neural tube formation | GO:0001841 | 108 | 0.026 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.026 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.026 | |
| cytokine secretion | GO:0050663 | 72 | 0.026 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.026 | |
| neural tube development | GO:0021915 | 160 | 0.026 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.026 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.026 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.026 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.026 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.026 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.025 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.025 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.025 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.025 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.025 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.025 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.025 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.025 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.025 | |
| defense response to virus | GO:0051607 | 68 | 0.025 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.025 | |
| methylation | GO:0032259 | 134 | 0.025 | |
| formation of organ boundary | GO:0010160 | 1 | 0.025 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.025 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.024 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.024 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.024 | |
| midgut development | GO:0007494 | 4 | 0.024 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.024 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.024 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.024 | |
| renal inner medulla development | GO:0072053 | 3 | 0.024 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.024 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.024 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.024 | |
| protein ubiquitination | GO:0016567 | 171 | 0.024 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.024 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.024 | |
| organelle fission | GO:0048285 | 170 | 0.024 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.024 | |
| cellular response to lipid | GO:0071396 | 145 | 0.023 | |
| t cell differentiation | GO:0030217 | 174 | 0.023 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.023 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.023 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.023 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.023 | |
| response to insulin | GO:0032868 | 100 | 0.023 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.023 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.023 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.023 | |
| spinal cord development | GO:0021510 | 81 | 0.023 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.023 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.023 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.023 | |
| granulocyte migration | GO:0097530 | 43 | 0.023 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.023 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.023 | |
| renal vesicle induction | GO:0072034 | 3 | 0.023 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.023 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.023 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.023 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.023 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.023 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.023 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.023 | |
| muscle cell development | GO:0055001 | 133 | 0.023 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.023 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.023 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.023 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.023 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.023 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.023 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.023 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.022 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.022 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.022 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.022 | |
| nephric duct formation | GO:0072179 | 4 | 0.022 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.022 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.022 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.022 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.022 | |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.022 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.022 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.022 | |
| sensory perception | GO:0007600 | 245 | 0.022 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.021 | |
| endothelial cell migration | GO:0043542 | 44 | 0.021 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.021 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.021 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.021 | |
| developmental cell growth | GO:0048588 | 84 | 0.021 | |
| thymocyte migration | GO:0072679 | 2 | 0.021 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.021 | |
| endocytosis | GO:0006897 | 168 | 0.021 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.021 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.021 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.021 | |
| neuronal action potential | GO:0019228 | 54 | 0.021 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.021 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.020 | |
| tissue migration | GO:0090130 | 68 | 0.020 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.020 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.020 | |
| b cell differentiation | GO:0030183 | 78 | 0.020 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.020 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.020 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.020 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.020 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.020 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.020 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.020 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.020 | |
| thymocyte apoptotic process | GO:0070242 | 19 | 0.020 | |
| gas homeostasis | GO:0033483 | 3 | 0.020 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.020 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.020 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.020 | |
| synaptic transmission | GO:0007268 | 329 | 0.020 | |
| axonogenesis | GO:0007409 | 274 | 0.020 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.020 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.020 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.019 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.019 | |
| cellular extravasation | GO:0045123 | 17 | 0.019 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.019 | |
| response to retinoic acid | GO:0032526 | 56 | 0.019 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.019 | |
| regulation of cell size | GO:0008361 | 72 | 0.019 | |
| skin development | GO:0043588 | 220 | 0.019 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.019 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.019 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.019 | |
| blood circulation | GO:0008015 | 195 | 0.019 | |
| placenta development | GO:0001890 | 140 | 0.019 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.019 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.019 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.019 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.019 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.019 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.019 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.019 | |
| foregut regionalization | GO:0060423 | 3 | 0.019 | |
| positive regulation of meiosis | GO:0045836 | 14 | 0.019 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.019 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.019 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.019 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.019 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.019 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 39 | 0.018 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.018 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.018 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.018 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.018 | |
| hormone secretion | GO:0046879 | 128 | 0.018 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.018 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.018 | |
| protein localization to organelle | GO:0033365 | 185 | 0.018 | |
| pallium development | GO:0021543 | 120 | 0.018 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.018 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.018 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.018 | |
| regulation of cell growth | GO:0001558 | 91 | 0.018 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.018 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.018 | |
| response to steroid hormone | GO:0048545 | 56 | 0.018 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.018 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.018 | |
| lung field specification | GO:0060424 | 3 | 0.018 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.018 | |
| lateral line system development | GO:0048925 | 1 | 0.018 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.018 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.018 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.018 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.018 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.017 | |
